Rod Raynovich's  Instablog

Rod Raynovich
Send Message
Rod Raynovich is an entrepreneur and executive with a focus on life science companies and medical technology trends.He has over 30 years executive experience including Abbott and JNJ and has been involved three successful start-ups. He has a B.S, from Penn State University and an MBA from... More
My company:
Raygent Capital
My blog:
  • Risk Is Rising-Caution In Biopharmaceutical Stocks 0 comments
    Oct 7, 2013 12:55 PM | about stocks: IBB, CLDX

    Our Indicators Flash a Caution Signal Today

    No Change in Portfolio Picks

    If you are not at 10% cash in your biotechnology portfolio it is time to take profits or hedge your portfolio. If your biotech stock did not hit a new high last week you may want to sell it. Risk is rising and a red screen shows it. Although we expect another rally in the December/January time frame the sector has become frothy and overextended. Moreover, political dysfunction in Washington combined with an expected rise in interest rates in 2014 will limit upside in 2014. Here is where we are YTD:

    The IBB (see chart below) is up 52% YTD. The XBI ($129) is up 48% YTD.

    The Fidelity Select Biotechnology Fund (MUTF:FBIOX) is up 62% YTD.

    Our best picks have had huge moves YTD: Albany Molecular (NASDAQ:AMRI), Astex (NASDAQ:ASTX),Gilead (NASDAQ:GILD), Biogen Idec (NASDAQ:BIIB), Regeneron (NASDAQ:REGN), Pharmacyclics (NASDAQ:PCYC), and Seattle Genetics (NASDAQ:SGEN). All of these stocks are down today.

    Our mid-cap index is very red today with many high fliers down 3% or more on good volume: Aegerion (AEGR $92.91) off 4.45%, Alnylam (ALNY $61.65) of 4.6%,Celldex (CLDX $31.60) off 3%, Incyte ($ 38.52)., Isis (ISIS $34.45) of 4.45%. Sarepta Therapeutics (SRPT $54.45) is up 1.83%.

    The easy money has been made in 2013 and the bull market in biotech is now 4 years old. Stay with your core positions but get more defensive. Momentum is fading.

    Disclosure: I am long GILD.

    Additional disclosure: Long sector with FBIOX

    Stocks: IBB, CLDX
Back To Rod Raynovich's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers


More »

Latest Comments

Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.